MPM Oncology Impact Management GP LLC
Related Filers (14)
- Oncology Impact Fund (Cayman) Management L.P. (32)
- UBS Oncology Impact Fund L.P. (32)
- MPM Oncology Impact Management LP (32)
- GADICKE ANSBERT (19)
- Harpoon Therapeutics, Inc. (15)
- Cullinan Oncology, Inc. (4)
- iTeos Therapeutics, Inc. (4)
- SUNESIS PHARMACEUTICALS INC (3)
- TCR2 THERAPEUTICS INC. (2)
- Oncorus, Inc. (2)
- Werewolf Therapeutics, Inc. (2)
- MPM ONCOLOGY INNOVATIONS FUND LP (2)
- MPM Oncology Innovations Fund GP LLC (2)
- Spring Bank Pharmaceuticals, Inc. (1)
- Show More ...
Ownership (33)
4
Wednesday, 8/25/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/12/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/2/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/27/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/24/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/20/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/17/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/12/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/6/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/6/2021
Werewolf Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/4/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 4/29/2021
Werewolf Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 4/29/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/22/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/20/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/15/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/13/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/13/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/9/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3/A
Thursday, 1/14/2021
Cullinan Management, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 1/14/2021
Cullinan Management, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/8/2020
Oncorus, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/1/2020
Oncorus, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 7/30/2020
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/23/2020
iTeos Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 2/21/2019
TCR2 THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/14/2019
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/13/2019
TCR2 THERAPEUTICS INC.: Initial statement of beneficial ownership of securities
3
Thursday, 2/7/2019
Harpoon Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 2/6/2018
Spring Bank Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 11/6/2017
SUNESIS PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 11/6/2017
SUNESIS PHARMACEUTICALS INC: Major Shareholders
3
Tuesday, 10/31/2017
SUNESIS PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities